IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 126-150 out of 1124.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>

Public Release: 13-Nov-2012
PLOS ONE
A sip of resveratrol and a full p53: Ingredients for a successful cell death
Researchers at the Universidade Federal in Rio de Janeiro in Brazil have found that introduction of a normal copy of the p53 gene in p53-defective cancer cell lines makes these cells sensitive to the anti-tumor proprieties of resveratrol, the naturally occurring dietary compound found in red wine.
National Council for Scientific and Technological Development, Rio de Janeiro State Foundation for Research, Ministry of Health, Cancer Foundation, National Institute of Science and Technology for Structural Biol

Contact: Jerson Lima Silva
jerson@bioqmed.ufrj.br
55-212-562-6756
Publicase Comunicação Científica

Public Release: 13-Nov-2012
Radiology
Stereoscopic mammography could reduce recall rate
A new three-dimensional digital mammography technique has the potential to significantly improve the accuracy of breast cancer screening.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 13-Nov-2012
Cochrane Database of Systematic Reviews
Cancer: Exercise reduces tiredness
Aerobic exercise can help relieve the fatigue often associated with cancer and cancer treatment, according to Cochrane researchers. Their updated systematic review strengthens findings from an earlier version on cancer-related fatigue published in the Cochrane Library

Contact: Ben Norman
Sciencenewsroom@wiley.com
44-012-437-70375
Wiley

Public Release: 13-Nov-2012
Journal of Clinical Oncology
Terminally ill cancer patients who discuss end-of-life care early can avoid aggressive treatment
Terminally ill cancer patients who have an early talk with their physician about care at the end-of-life are less likely to receive aggressive therapy – and more likely to enter hospice care – than patients who delay such discussions until the days and weeks before death, a new study by Dana-Farber Cancer Institute researchers suggests.
NIH/National Cancer Institute, US Department of Veterans Affairs, American Cancer Society, and others

Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-5665
Dana-Farber Cancer Institute

Public Release: 13-Nov-2012
Carcinogenesis
Scientists discover how stomach cancer spreads
Scientists at the University of Liverpool have found that the production of a protein that prevents the growth and spread of cancerous cells is impaired in patients with gastric cancer.
National Institutes of Health, North West Cancer Research

Contact: Samantha Martin
samantha.martin@liv.ac.uk
44-015-179-42248
University of Liverpool

Public Release: 12-Nov-2012
Annals of Oncology
Awareness could eliminate inequalities in cancer diagnoses
There are substantial inequalities in the stage at which cancer patients receive their diagnosis -- a critical factor for cancer survival -- a new study by the University of Cambridge reveals. The researchers found that age, sex and income as well as the type of cancer influenced the risk of a patient being diagnosed at an advanced stage of the disease.

Contact: Genevieve Maul
Genevieve.maul@admin.cam.ac.uk
44-122-376-5542
University of Cambridge

Public Release: 12-Nov-2012
BMC Medicine
New studies shed light on what it cost to vaccinate girls against HPV in low income countries
Two studies published in BioMed Central's open access journal BMC Medicine examined the cost of delivering the human papillomavirus (HPV) vaccine to primary school girls in Tanzania. Both studies found that the cost of HPV vaccine delivery to adolescent girls may be substantially higher compared with the cost of delivering a new vaccine to an infant where the delivery schedule matches the existing infant immunization schedule.

Contact: Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central

Public Release: 12-Nov-2012
Journal of Clinical Investigation
JCI early table of contents for Nov. 12, 2012
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Nov. 12, 2012, in the JCI: Home field advantage: Intravaginal immunization may help protect against infection; HIV-1 vaccine development: pinning down a moving target; Researchers find abnormal dopamine signaling in a mouse model of Angelman's syndrome; A new view of the immune system; Unraveling the role of the unfolded protein response in cancer; and many more.

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 12-Nov-2012
Cancer Cell
Study shows how chronic inflammation can cause cancer
A new study has found that interleukin-15 (IL-15) alone can cause large granular lymphocytic (LGL) leukemia, a rare and usually fatal form of cancer. The researchers developed a treatment for the leukemia that showed no discernible side effects in an animal model. The study shows that IL-15 is also overexpressed in patients with LGL leukemia and that it causes similar cellular changes, suggesting that the treatment should also benefit people with the malignancy.
NIH/National Cancer Institute, National Science Foundation

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center

Public Release: 12-Nov-2012
Annals of Family Medicine
November/December 2012 Annals of Family Medicine tip sheet
This tip sheet offers synopses of original research and editorials included in the November/December 2012 issue of Annals of Family Medicine research journal.

Contact: Angela Sharma
asharma@aafp.org
913-269-2269
American Academy of Family Physicians

Public Release: 12-Nov-2012
Cancer
Black patients with kidney cancer have poorer survival than whites
Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that additional efforts are needed to prolong the survival of all patients with kidney cancer.

Contact: Amy Molnar
sciencenewsroom@wiley.com
Wiley

Public Release: 12-Nov-2012
Proceedings of the National Academy of Sciences
Catch and release
A research team at Brigham and Women's Hospital has developed a novel device that may one day have broad therapeutic and diagnostic uses in the detection and capture of rare cell types, such as cancer cells, fetal cells, viruses and bacteria.
National Institutes of Health

Contact: Marjorie Montemayor-Quellenberg
mmontemayor-quellenberg@partners.org
617-534-2208
Brigham and Women's Hospital

Public Release: 12-Nov-2012
Cancer Cell
Gene sequencing project identifies abnormal gene that launches rare childhood leukemia
Research led by the St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis.
National Institutes of Health, Pediatric Cancer Genome Project, ALSAC, and others.

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital

Public Release: 12-Nov-2012
International Conference on Pattern Recognition (ICPR 2012) Tsukuba, Japan
New statistical method offers automatic mitotic cell detection for cancer diagnosis
Scientists have developed a statistical image analysis method which can assist in the grading of breast cancer by automatically segmenting tumour regions and detecting dividing cells in tissue samples.

Contact: Anna Blackaby
44-024-765-75910
University of Warwick

Public Release: 12-Nov-2012
Nature Genetics
Duke Medicine news -- Genome sequencing of Burkitt Lymphoma reveals unique mutation
In the first broad genetic landscape mapped of a Burkitt lymphoma tumor, scientists at Duke Medicine and their collaborators identified 70 mutations, including several that had not previously been associated with cancer and a new one that was unique to the disease.
National Institutes of Health, American Cancer Society

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 12-Nov-2012
Nanotechnology
UT Arlington physics team demonstrates new power generation technique
University of Texas at Arlington and Louisiana Tech University researchers created a hybrid nanomaterial that can be used to convert light and thermal energy into electrical current. The team built a prototype thermoelectric generator they hope can eventually produce milliwatts for use in devices such as self-powering sensors, low-power electronic devices and implantable biomedical micro-devices, they said. UT Arlington's Wei Chen has also coupled gold nanoparticles with copper sulfide nanoparticles for potential use in cancer therapy.

Contact: Traci Peterson
tpeterso@uta.edu
817-272-9208
University of Texas at Arlington

Public Release: 12-Nov-2012
Cancer Cell
Scientists at IRB BARCELONA discover a key process that allows colon cancer to metastasize
Researchers at the IRB Barcelona have determined that the ability of colon cancer to metastasize lies in the healthy cells, called stroma, that surround the tumor. Although the stroma has long been hypothesized to be complicit in this process, this study marks the first time that healthy cells in the microenvironment have been observed to play a fundamental role in allowing metastasis to occur in a specific tumor type.

Contact: Sònia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)

Public Release: 12-Nov-2012
Deutsches Ärzteblatt International
Place in the sun carries risks for outdoor workers
Those individuals who work outdoors with resultant sun exposure are at increased risk for non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma. Manige Fartasch shows that the connection between occupational UV exposure and squamous cell carcinoma is now well-established in her review article in issue 43 of Deutsches Arzteblatt International.

Contact: Manigé Fartasch
fartasch@ipa.ruhr-uni-bochum.de
Deutsches Aerzteblatt International

Public Release: 12-Nov-2012
Cancer Discovery
PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers
PI3-kinase inhibitors sensitized tumors to PARP inhibitors. Combination significantly prolonged progression-free survival in mouse model.
Stand Up To Cancer

Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research

Public Release: 11-Nov-2012
Nature Medicine
Detection, analysis of 'cell dust' may allow diagnosis, monitoring of brain cancer
A novel miniature diagnostic platform using nuclear magnetic resonance technology is capable of detecting minuscule cell particles known as microvesicles in a drop of blood. Microvesicles shed by cancer cells are even more numerous than those released by normal cells, so detecting them could prove a simple means for diagnosing cancer.
National Institutes of Health

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 11-Nov-2012
Nature Genetics
Gene variations linked to lung cancer susceptibility in Asian women
An international group of scientists has identified three genetic regions that predispose Asian women who have never smoked to lung cancer. The finding provides further evidence that risk of lung cancer among never-smokers, especially Asian women, may be associated with certain unique inherited genetic characteristics that distinguishes it from lung cancer in smokers.
NIH/National Cancer Institute

Contact: NCI Press Office
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute

Public Release: 9-Nov-2012
Cancer Research
New mechanism of action for PARP inhibitors discovered
PARP inhibitors are promising treatments for BRCA-mutant breast and ovarian cancers. Researchers have identified a new way in which these drugs work. New genetic mutations rendering cells susceptible to PARP inhibitors are also identified. Patients with tumors bearing these mutations might benefit from PARP inhibitors.

Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research

Public Release: 9-Nov-2012
Cancer Research
Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
Researchers at Moffitt Cancer Center have identified metabolic signatures that may pave the way for personalized therapy in glioma, a type of tumor that starts in the brain.
US Army Medical Research and Materiel Command, American Cancer Society

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute

Public Release: 9-Nov-2012
Proceedings of the National Academy of Sciences
A comparative medicine study by Penn vet identifies a new approach to combat viral infections
When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack. A study by scientists from the University of Pennsylvania School of Veterinary Medicine offers a new strategy for enhancing the effects of interferon in fighting off infection.
National Institutes of Health, University of Pennsylvania

Contact: Katherine Unger Baillie
kbaillie@upenn.edu
215-898-9194
University of Pennsylvania

Public Release: 9-Nov-2012
Journal of Andrology
Compound in grapes, red wine could be key to fighting prostate cancer
A University of Missouri researcher has discovered that the compound can make prostate tumor cells more susceptible to radiation treatment, increasing the chances of a full recovery from all types of prostate cancer, including aggressive tumors.

Contact: Christian Basi
BasiC@missouri.edu
573-882-4430
University of Missouri-Columbia

Showing releases 126-150 out of 1124.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>

  Search News Releases

     

 

 

EurekAlert!